Discovery of extracellular vesicles derived miR-181a-5p in patient's serum as an indicator for bone-metastatic prostate cancer
Conclusion: EV-delivered miR-181a-5p from patient's serum is a promising diagnostic biomarker for bone metastatic prostate cancer.
Source: Theranostics - Category: Molecular Biology Authors: Yanqing Wang, Yu-Xiang Fang, Baijun Dong, Xinxing Du, Jialin Wang, Xiao Wang, Wei-Qiang Gao, Wei Xue Tags: Research Paper Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Molecular Biology | Prostate Cancer